Brincidofovir (BCV)

Brincidofovir (BCV) is an oral antiviral designed to treat viral infections like smallpox by drug delivery to the intracellular site of viral replication. BCV penetrates cells via its lipid conjugate technology, releasing the nucleotide analog cidofovir, which then acts to inhibit virus replication.

Notify me on updates of this product 

Availability: In Development

busdev@chimerix.com
+1 919 806 1074
2505 Meridian Parkway, Suite 100
Durham, NC 27713
USA
www.chimerix.com/our-focus/biodefense/
Manufacturer
Chimerix, Inc.
Product Name
Brincidofovir (BCV)
Detection Category
Biological
Detection Method
PPE/Decon;
Application
Personal Protective Equipment;
Equipment Type
PPE
Product Synopsis
Brincidofovir (BCV) is an oral antiviral designed to treat viral infections like smallpox by drug delivery to the intracellular site of viral replication. BCV penetrates cells via its lipid conjugate technology, releasing the nucleotide analog cidofovir, which then acts to inhibit virus replication.
Availability
In Development
Technology Readiness Level (TRL)
6
User Feedback Sources
Indifferent/No user feedback
Weight
<1 lb.
Transportability
Pocket Size
Live Agent Tested
Yes
Operating Time
Immediate post-exposure use
Training Required
<1 hour training
Training Available
Yes
Manuals Available
Yes
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: